Theriva Biologics, Inc. Logo

Theriva Biologics, Inc.

Clinical-stage company developing systemically delivered oncolytic virus therapies.

TOVX | US

Overview

Corporate Details

ISIN(s):
US87164U5083 (+1 more)
LEI:
Country:
United States of America
Address:
9605 MEDICAL CENTER DRIVE, 20850 ROCKVILLE

Description

Theriva Biologics, Inc. is a clinical-stage immuno-oncology company developing a new class of oncolytic virus therapeutics. The company's platform is engineered for systemic delivery to overcome the protective barrier surrounding solid tumors. These developmental therapies are designed to selectively replicate within and kill tumor cells, with the potential to enhance current standard-of-care treatments. Theriva's lead candidates are being advanced to address a range of difficult-to-treat cancers and diseases in areas of high unmet medical need.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-08-02 11:22
FORM 8-K
English 105.5 KB
2023-06-27 19:11
FORM 8-K
English 106.0 KB
2023-06-08 09:00
OWNERSHIP DOCUMENT
English 7.5 KB
2023-06-07 09:00
OWNERSHIP DOCUMENT
English 7.5 KB
2023-05-11 10:15
10-Q
English 1.7 MB
2023-05-11 10:10
FORM 8-K
English 125.1 KB
2023-03-30 10:16
10-K
English 3.9 MB
2023-03-30 10:15
FORM 8-K
English 116.8 KB
2023-03-10 18:01
FORM 8-K
English 86.1 KB
2023-02-16 17:09
FORM 8-K
English 1.4 MB
2023-02-13 07:06
OWNERSHIP DOCUMENT
English 7.4 KB
2023-02-03 07:02
OWNERSHIP DOCUMENT
English 7.4 KB
2023-01-26 07:03
OWNERSHIP DOCUMENT
English 7.5 KB
2023-01-23 07:08
FORM 4
English 6.9 KB
2023-01-17 09:10
FORM 8-K
English 125.9 KB

Automate Your Workflow. Get a real-time feed of all Theriva Biologics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Theriva Biologics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Theriva Biologics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.